User Experiences With a Type 2 Diabetes Coaching App: Qualitative Study.
mHealth
mobile apps
mobile phone
self-management
smartphone
type 2 diabetes
Journal
JMIR diabetes
ISSN: 2371-4379
Titre abrégé: JMIR Diabetes
Pays: Canada
ID NLM: 101719410
Informations de publication
Date de publication:
17 07 2020
17 07 2020
Historique:
received:
31
10
2019
accepted:
05
05
2020
revised:
08
03
2020
entrez:
25
7
2020
pubmed:
25
7
2020
medline:
25
7
2020
Statut:
epublish
Résumé
Diabetes self-management apps have the potential to improve self-management in people with type 2 diabetes (T2D). Although efficacy trials provide evidence of health benefits, premature disengagement from apps is common. Therefore, it is important to understand the factors that influence engagement in real-world settings. This study aims to explore users' real-world experiences with the My Diabetes Coach (MDC) self-management app. We conducted telephone-based interviews with participants who had accessed the MDC self-management app via their smartphone for up to 12 months. Interviews focused on user characteristics; the context within which the app was used; barriers and facilitators of app use; and the design, content, and delivery of support within the app. A total of 19 adults with T2D (8/19, 42% women; mean age 60, SD 14 years) were interviewed. Of the 19 interviewees, 8 (42%) had T2D for <5 years, 42% (n=8) had T2D for 5-10 years, and 16% (n=3) had T2D for >10 years. In total, 2 themes were constructed from interview data: (1) the moderating effect of diabetes self-management styles on needs, preferences, and expectations and (2) factors influencing users' engagement with the app: one size does not fit all. User characteristics, the context of use, and features of the app interact and influence engagement. Promoting engagement is vital if diabetes self-management apps are to become a useful complement to clinical care in supporting optimal self-management. Australia New Zealand Clinical Trials Registry CTRN126140012296; URL https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366925&isReview=true.
Sections du résumé
BACKGROUND
Diabetes self-management apps have the potential to improve self-management in people with type 2 diabetes (T2D). Although efficacy trials provide evidence of health benefits, premature disengagement from apps is common. Therefore, it is important to understand the factors that influence engagement in real-world settings.
OBJECTIVE
This study aims to explore users' real-world experiences with the My Diabetes Coach (MDC) self-management app.
METHODS
We conducted telephone-based interviews with participants who had accessed the MDC self-management app via their smartphone for up to 12 months. Interviews focused on user characteristics; the context within which the app was used; barriers and facilitators of app use; and the design, content, and delivery of support within the app.
RESULTS
A total of 19 adults with T2D (8/19, 42% women; mean age 60, SD 14 years) were interviewed. Of the 19 interviewees, 8 (42%) had T2D for <5 years, 42% (n=8) had T2D for 5-10 years, and 16% (n=3) had T2D for >10 years. In total, 2 themes were constructed from interview data: (1) the moderating effect of diabetes self-management styles on needs, preferences, and expectations and (2) factors influencing users' engagement with the app: one size does not fit all.
CONCLUSIONS
User characteristics, the context of use, and features of the app interact and influence engagement. Promoting engagement is vital if diabetes self-management apps are to become a useful complement to clinical care in supporting optimal self-management.
TRIAL REGISTRATION
Australia New Zealand Clinical Trials Registry CTRN126140012296; URL https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366925&isReview=true.
Identifiants
pubmed: 32706649
pii: v5i3e16692
doi: 10.2196/16692
pmc: PMC7395244
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e16692Investigateurs
Anthony Russell
(A)
Paul Scuffham
(P)
Michaela A Riddell
(MA)
Emily D Williams
(ED)
Informations de copyright
©Shaira Baptista, Greg Wadley, Dominique Bird, Brian Oldenburg, Jane Speight, The My Diabetes Coach Research Group. Originally published in JMIR Diabetes (http://diabetes.jmir.org), 17.07.2020.
Références
Diabetes Technol Ther. 2019 Jul;21(7):393-399
pubmed: 31166804
JMIR Mhealth Uhealth. 2013 Mar 27;1(1):e1
pubmed: 25100649
Diabetes Obes Metab. 2018 Aug;20(8):2009-2013
pubmed: 29582538
Curr Diab Rep. 2011 Dec;11(6):486-93
pubmed: 21960031
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
Health Educ Res. 2006 Feb;21(1):97-107
pubmed: 15996975
Stud Health Technol Inform. 2013;192:127-31
pubmed: 23920529
J Med Internet Res. 2005 Mar 31;7(1):e11
pubmed: 15829473
Diabet Med. 2017 Jan;34(1):14-26
pubmed: 26996982
JMIR Serious Games. 2014 Aug 04;2(2):e9
pubmed: 25654660
BMJ. 2012 Apr 26;344:e2333
pubmed: 22539172
J Med Internet Res. 2014 May 09;16(5):e125
pubmed: 24824062
Int J Equity Health. 2019 Jan 24;18(1):19
pubmed: 30678694
JMIR Serious Games. 2013 Dec 12;1(1):e3
pubmed: 25658754
PLoS One. 2016 May 23;11(5):e0156164
pubmed: 27214203
JMIR Diabetes. 2018 May 11;3(2):e9
pubmed: 30291098
Diabetes Res Clin Pract. 2017 Sep;131:70-81
pubmed: 28692830
Diabet Med. 2015 Jan;32(1):120-8
pubmed: 25081181
Int J Med Inform. 2019 Oct;130:103941
pubmed: 31437618
JMIR Mhealth Uhealth. 2019 Jul 10;7(7):e13817
pubmed: 31293246
J Med Internet Res. 2011 Jan 25;13(1):e9
pubmed: 21371992
J Med Internet Res. 2018 Mar 16;20(3):e81
pubmed: 29549070
J Diabetes Metab Disord. 2013 Mar 05;12(1):14
pubmed: 23497559
BMC Health Serv Res. 2019 Sep 6;19(1):641
pubmed: 31492176
Diabet Med. 2013 May;30(5):620-6
pubmed: 23181664
Diabet Med. 2011 Apr;28(4):455-63
pubmed: 21392066
Patient Educ Couns. 2016 Jan;99(1):101-7
pubmed: 26319362
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Am J Health Behav. 2014 Nov;38(6):860-70
pubmed: 25207512
J Nutr Educ Behav. 2018 Jan;50(1):62-69.e1
pubmed: 29325664
Int J Nurs Stud. 2019 Feb 8;:103286
pubmed: 30827741
Diabetes Educ. 2018 Feb;44(1):35-50
pubmed: 29346744
J Med Internet Res. 2018 Jan 29;20(2):e40
pubmed: 29463488
Diabetes Care. 2001 Mar;24(3):561-87
pubmed: 11289485
Diabetes Res Clin Pract. 2019 Mar;149:39-46
pubmed: 28951337
Diabetes Technol Ther. 2012 Dec;14(12):1178-82
pubmed: 23013155
Lancet Diabetes Endocrinol. 2018 Feb;6(2):130-142
pubmed: 28970034
Diabetes Technol Ther. 2017 Dec;19(12):730-738
pubmed: 29028442
J Med Internet Res. 2015 Aug 19;17(8):e202
pubmed: 26290186
Health Promot Int. 2013 Sep;28(3):285-98
pubmed: 22241853
Diabetes Technol Ther. 2017 Jan;19(1):9-17
pubmed: 28099052
Med 2 0. 2015 Mar 02;4(1):e1
pubmed: 25733033
Health Psychol. 2007 Nov;26(6):728-734
pubmed: 18020845